Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2022-12-02 00:00:00 ET · period of report 2022-12-01 · accession 0001104659-22-124079 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-02 | 2022-12-01 | ANIP | Meridian Venture Partners II GP, L.P. | 10% | S - Sale | $38.50 | -200.0K | 2.02M | -9% | -$7.70M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-01 | S | D | 200,000 | $38.50 | 2,019,259 | D | — | — | (F1) Meridian Venture Partners II, L.P. sold the shares that are the subject of this Form 4 for its liquidity purposes, and no additional sales are planned at this time. |